Cancer

Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation

Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated debut in JulyWith a fully…

8 months ago

RaySearch to showcase its latest innovations in RayStation, RayCare, and RayIntelligence at ESTRO 2025

STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce our participation at ESTRO in Vienna,…

8 months ago

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

PHILADELPHIA, May 2, 2025 /PRNewswire/ -- Darnatein, a subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), a biotechnology company advancing design-augmented…

8 months ago

RaySearch releases RayStation v2025

STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the launch of RayStation®* v2025, the latest version of…

8 months ago

Fueling Breakthroughs: The Melanoma Research Alliance Announces $9.3M Melanoma Research Investment

WASHINGTON, May 1, 2025 /PRNewswire/ -- The Melanoma Research Alliance (MRA), the world's leading non-profit funder of melanoma research, announced…

8 months ago

Communication Breakdowns Are a Major Hurdle for Caregivers

New ASHA–YouGov Poll Reveals Experiences of Caregivers of People With Communication and Other Challenges Caregivers Highly Rate the Help of…

8 months ago

Sona Nanotech Announces Annual Options Grants

Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona")…

8 months ago

Entos Pharmaceuticals (Entos) Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference

Edmonton, Alberta--(Newsfile Corp. - May 1, 2025) - Entos Pharmaceuticals (Entos), a clinical-stage genetic medicines company headquartered in Edmonton, Canada,…

8 months ago

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a…

8 months ago